Skip to content
Elekta Versa HD Radiation Therapy
Radiation Oncology

Elekta Versa HD Radiation Therapy

About This Department

 
Radiation oncology

The linear accelerator at Biruni Hospital shapes each beam with 160 tungsten leaves and holds its aim to within a millimeter. The machine is the tool. The plan is the treatment.

The Elekta Versa HD is a linear accelerator, the standard machine for external beam radiation therapy, fitted with a 160-leaf collimator that sculpts the beam to the outline of a tumor from every angle, high dose rate beams for short treatments of small targets, and a built-in CT scanner that checks the patient's position before each session. Physicists who commissioned one measured the rotation of its gantry, collimator and couch to within one millimeter of a single point (Narayanasamy and colleagues, Journal of Applied Clinical Medical Physics, 2016). That precision is what allows the treatments described on this page, from a five-session course for early breast cancer to a single high dose to a metastasis in the lung or spine. This page explains what the machine does, which cancers it treats and by which techniques, what the trials say about shorter courses, what the path from first visit to last session looks like, the side effects, and how patients from abroad arrange radiation therapy at Biruni Hospital in Istanbul.

160
Leaves in the collimator that shapes the beam, each 5 millimeters wide at the center of the field
1
Millimeter or less of variation in the point where gantry, collimator and couch rotations meet
5
Sessions in one week for early breast cancer, shown non-inferior to 15 sessions over three weeks
Free
Review of your pathology, scans and any earlier radiation record
Free consultation

What the Versa HD is

A linear accelerator makes X-rays of far higher energy than a diagnostic machine, points them at a tumor from a rotating arm, and shapes the beam so that the tumor receives the prescribed dose while the tissue around it receives as little as the geometry allows. Every modern radiation therapy course, whatever the cancer, is delivered on a machine of this kind. The Versa HD is Elekta's current design, and Biruni Hospital treats on one.


What the hardware does

  • The collimator, called Agility, carries 160 tungsten leaves that slide in and out under computer control as the arm rotates, so that the beam's outline changes continuously to match the shape of the tumor from each direction. Leaf transmission was measured at about half a percent, meaning almost nothing leaks through the closed leaves.
  • Flattening filter free beams remove a metal cone from the beam path and deliver dose at up to four times the ordinary rate. Forty minutes becomes ten. That matters when a patient must hold still and hold a breath.
  • An X-ray panel and a cone beam CT scanner mounted on the arm image the patient on the treatment couch before each session. The picture is matched to the planning scan and the couch moves to correct any difference, in six directions, before the beam starts.
  • A surface camera system and breath-hold monitoring, where fitted, track the patient's chest during treatment of the left breast and the lung, so that the heart stays out of the field.

Techniques and cancers

One machine. Several techniques, which differ in how finely the dose is shaped, how many sessions it is split into and how much imaging is done at each.

What is the difference between IMRT, VMAT and SBRT?
Intensity modulated radiation therapy, IMRT, varies the strength of the beam across its width from several fixed angles. Volumetric modulated arc therapy, VMAT, does the same while the arm rotates around the patient in one or two continuous arcs, which is faster and shapes the dose more tightly. Both are used for courses of 15 to 35 sessions. Stereotactic body radiation therapy, SBRT, also called SABR, gives a much higher dose per session in one to five sessions to a small target, with millimeter positioning at each. Stereotactic radiosurgery, SRS, applies the same idea to the brain, where a single session through a frameless mask can treat several metastases at once. All four run on the Versa HD.
Is it the same as CyberKnife or Gamma Knife?
No. The hospital has neither, and neither is needed for the treatments described on this page, since both are dedicated to stereotactic treatment of small targets and nothing else. A linear accelerator with a fine collimator, high dose rate beams and cone beam imaging delivers stereotactic treatment to the brain, spine, lung, liver and prostate with comparable precision, and it also delivers the long conventional courses that those machines cannot. For most patients the choice of machine matters less than the experience of the team planning on it.
Gantry, collimator and couch isocentricity measurements were within 1 mm, 0.7 mm and 0.7 mm diameter respectively (Narayanasamy and colleagues, 2016).

Cancers treated

  1. Breast. After lumpectomy or mastectomy, to the whole breast or chest wall and, where needed, the lymph nodes, with breath-hold to protect the heart on the left side.
  2. Prostate. Moderate hypofractionation over four weeks, or SBRT in five sessions for selected patients, with markers or a spacer gel where indicated.
  3. Lung. SBRT for early tumors in patients who cannot or prefer not to have surgery, and conventional courses with chemotherapy for locally advanced disease.
  4. Head and neck. Six to seven week VMAT courses that spare the salivary glands and the swallowing muscles as far as the tumor allows.
  5. Brain. Radiosurgery for metastases and benign tumors in a frameless mask, and whole brain or partial brain courses where needed.
  6. Metastases in bone, liver, lymph nodes and adrenal. SBRT for a limited number of metastases, and short palliative courses for pain.
  7. Rectum, cervix, esophagus, bladder, lymphoma, sarcoma and skin. Conventional and hypofractionated courses, with chemotherapy where the protocol calls for it.

What it does not do

Protons. Brachytherapy, in which a source is placed inside the body, is a separate service and a separate question. And a linear accelerator treats what can be seen and outlined on a scan, so a cancer that has spread widely is treated with drugs, with radiation reserved for the sites that hurt or threaten.

Fewer sessions, same result

Not a machine. The most important change in radiation therapy over the past fifteen years has been the finding, in large randomized trials, that many cancers can be treated in far fewer sessions with a higher dose at each, without loss of control and without more side effects, provided the delivery is precise enough. The Versa HD was built for that kind of delivery.

26 Gy in five fractions over 1 week is non-inferior to the standard of 40 Gy in 15 fractions over 3 weeks for local tumor control, and is as safe in terms of normal tissue effects up to 5 years (Murray Brunt and colleagues, Lancet, 2020).
The FAST-Forward trial randomized 4,096 women with early breast cancer at 97 British hospitals. At five years, recurrence in the treated breast was 2.1 percent after three weeks of treatment and lower still after the one-week schedule. One week, in place of a month in Istanbul.
1
Prostate
The CHHiP trial randomized 3,216 men to 37 sessions over seven and a half weeks or 20 sessions over four. At five years, 90.6 percent of the 20-session group were free of failure against 88.3 percent of the 37-session group, with the same long-term side effects, and 20 sessions became the recommended standard (Dearnaley and colleagues, Lancet Oncology, 2016).
2
A few metastases
The SABR-COMET trial randomized 99 patients with a controlled primary cancer and one to five metastases to standard palliative care or the same plus stereotactic radiation to every metastasis. Median survival rose from 28 months to 41 months. Serious side effects were more frequent after SABR and three patients died of treatment, which is the reason it is offered by experienced teams to selected patients (Palma and colleagues, Lancet, 2019).
3
Lung and elsewhere
SBRT in three to five sessions controls early lung cancer in roughly nine of ten patients unfit for surgery, and shorter schedules are now standard for bone metastases, glioblastoma in older patients and rectal cancer before surgery.
 
Shorter is not always better. Head and neck cancer, cervical cancer and most lymphomas are still treated in daily sessions over several weeks because the trials that would justify fewer sessions have not been done or have failed. The cancer sets the schedule, and the file review will say what the schedule for a given patient would be.

From first visit to first session

Seven to ten days, for most courses.

The steps

First, the radiation oncologist reviews the pathology, the scans and any previous treatment, examines the patient and confirms the intent, whether cure, control or relief of symptoms, and the technique and schedule. The patient then has a planning CT in the treatment position, lying on a mold or a mask made that day, with the scan sometimes fused to an MRI or a PET. Over the following days the oncologist outlines the tumor and every organ near it on each slice of that scan, a physicist and a dosimetrist build a plan that meets the prescribed dose to the target and the limits set for each organ, and the plan is checked by a second physician and by measurement on the machine itself before the patient is called. The first session runs long. It includes a verification image. A patient who has already had the planning scan and the outlining done at home cannot reuse them, because the plan belongs to the machine it was made for, but the scans and the previous dose record are essential and shorten the review.

What a session is like

Painless, and shorter than the wait for it.

  • The radiation therapists position the patient on the couch using the mold or mask and the skin marks from planning, then leave the room and watch on camera and intercom.
  • The cone beam CT runs, the image is matched to the plan, and the couch moves. This takes two to three minutes and is the part that makes the precision possible.
  • The arm rotates and the beam runs. A conventional VMAT session lasts two to four minutes of beam time. A stereotactic session on the high dose rate beam lasts five to fifteen minutes. The patient feels nothing and hears a hum.

1
Conventional course
Once a day, five days a week, at the same time each day, for the number of weeks the schedule sets. Weekends off. A review with the oncologist once a week.
2
Stereotactic course
One to five sessions, every day or every other day, each preceded by more imaging and sometimes by a breath-hold rehearsal.
3
Between sessions
Ordinary life. Patients walk, eat, work and see the city, keep the treated skin out of the sun and wash it with plain soap.
 

Side effects

Where the beam goes decides them.

Tiredness that builds over a long course and lifts within weeks of the end. Skin reddening and soreness in the treated area. Then the effects of the organ in the field, which the oncologist describes in detail at the first visit. Sore throat and dry mouth in the head and neck. Bowel and bladder irritation in the pelvis. Cough or a sore esophagus in the chest. Hair loss only where the beam crosses the scalp.

Late effects

A small number of patients develop effects months or years later, such as stiffness in a treated breast, a change in bowel habit after pelvic treatment, or a narrowing of a treated airway. The trials cited above measured these carefully. In CHHiP, grade 2 or worse bowel effects at five years were 11.9 percent after 20 sessions and 13.7 percent after 37. In FAST-Forward, moderate or marked changes in the breast at five years were 11.9 percent after the one-week schedule and 9.9 percent after three weeks, a difference the trial judged acceptable. The dose limits for each organ in the plan exist to keep these numbers where the trials found them, and a plan that cannot meet them is redesigned before it is delivered.

Coming from abroad

Radiation therapy is one of the treatments patients travel for most often, because the schedule is predictable, the cost is a known quantity, and a modern machine with an experienced team is not available everywhere.


One coordinator from the international patients office handles arrangements from the first message through the last session and answers the same WhatsApp number once you are back home. The office works in English, Arabic, French, Russian, Serbian, Romanian and Spanish and books interpreters for other languages. It arranges the visa invitation letter, airport transfers, daily transport to the hospital for every session and accommodation near the hospital for the length of the course. The kitchen prepares halal, vegetarian and diabetic meals, a prayer room is on site, and a request for a female physician is met wherever the rota allows.
1
What to send
The pathology report, the staging scans as image files rather than reports alone, any previous radiation record with the dose and the fields, the list of medicines, and a summary of chemotherapy or surgery received. The radiation oncology team replies within a few working days with the proposed technique, the number of sessions, the length of stay and a cost estimate.
2
The stay
Planning in the first week, then the course. A five-session breast or prostate course means a stay of two to three weeks including planning. A twenty-session course means five to six weeks. Stereotactic treatment of a single metastasis can be done in ten days.
3
Going home
Patients are fit to fly the day after the last session. They leave with the full dose record, the plan images on disk for any future oncologist, a letter for the treating doctor at home and the date of the first follow-up scan. The coordinator arranges the review of that scan by the same oncologist.
 

Combining treatment

Patients who need chemotherapy alongside radiation receive it in the hospital's medical oncology unit on the same days, and those who need surgery first are scheduled so that radiation follows in the window the protocol requires.

Cost

An estimate follows the file review and depends on the technique, the number of sessions, whether imaging is done at every session and whether chemotherapy runs alongside. Hospitals in this market quote radiation therapy as a package for the course, with planning, imaging and weekly reviews included and accommodation listed separately.

Confirm what the figure includes and whether the follow-up scan is priced with it.

References

  1. Narayanasamy G, Saenz D, Cruz W, Ha CS, Papanikolaou N, Stathakis S. Commissioning an Elekta Versa HD linear accelerator. J Appl Clin Med Phys. 2016;17(1):179-191.
  2. Murray Brunt A, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward). 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613-1626.
  3. Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer. 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047-1060.
  4. Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET). A randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051-2058.

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Özcan YILDIZ, Medical Oncology.

Related Treatments

View All